相关实验视频
Updated: Jan 8, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
巨细胞在癌症中的作用:从基础研究到临床应用
Zhimei Liu1, Yan Li2, Jingchao Cao1
1Beijing Key Laboratory for Animal Genetic Improvement, National Engineering Laboratory for Animal Breeding, Key Laboratory of Animal Genetics and Breeding of the Ministry of Agriculture, College of Animal Science and Technology, National Research Facility for Phenotypic and Genotypic Analysis of Model Animals (Beijing) China Agricultural University Beijing China.
瘤相关巨细胞 (TAMs) 在癌症中具有双重作用,促进或阻碍抗瘤免疫力. 了解TAM可塑性和针对它们进行治疗,就像CAR-Ms一样,可以通过重塑瘤微环境来改善癌症免疫治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 巨细胞是瘤微环境 (TME) 中关键的先天性免疫细胞.
- 瘤相关巨细胞 (TAMs) 来自招募的单细胞,并表现出不同的M1 (抗瘤) 和M2 (前瘤) 现型.
- 控制TAM可塑性和两极化的机制尚未完全理解.
研究的目的:
- 在TME中全面审查TAM的起源,两极分化和功能多样性.
- 强调调节TAM介导免疫反应的途径.
- 检查当前和新兴的TAM向治疗策略.
主要方法:
- 文献综述综合了关于TAMs的当前研究.
- 分析调节TAM极化和功能的途径.
- 检查针对TAMs的治疗策略.
主要成果:
- TAMs具有显著的功能可塑性,影响抗瘤免疫力或瘤进展.
- M1 TAMs增强抗瘤反应,而M2 TAMs促进血管生成,入侵和免疫逃逸.
- 目前正在开发各种治疗策略,包括招募抑制,表型重编程和CAR-Ms.
结论:
- 向TAM对癌症免疫治疗具有显著的翻译潜力.
- 了解TAM可塑性是开发有效疗法的关键.
- 通过TAM调制重塑免疫抑制性TME可以提高治疗效率.
相关概念视频
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The Tumor Microenvironment

